Implementing ADDC Assays in QC
Inherent donor variability of immune effector cells presents a significant challenge for developing a robust and reproducible ADCC assays for QC lot release. DiscoverX recently introduced the single donor-derived KILR CD16 Effector Cells to ensure assay reproducibility for screening, characterisation, and QC lot release of antibody drugs.
The webinar focused on 2 qualification studies that were performed using these effectors to demonstrate accuracy and precision in different assay formats.